Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,775 | -20,167 | -8,603 | -55,064 | -46,500 |
| Depreciation Amortization | -685 | -195 | 10 | 761 | 703 |
| Accounts receivable | 225 | 146 | 178 | 1 | 158 |
| Accounts payable and accrued liabilities | 557 | 423 | 864 | -1,025 | -1,161 |
| Other Working Capital | -5,273 | -1,179 | -467 | -172 | -903 |
| Other Operating Activity | 3,663 | 2,214 | 313 | 21,840 | 20,291 |
| Operating Cash Flow | $-34,287 | $-18,759 | $-7,705 | $-33,659 | $-27,412 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 47 | 74 | 41 | -67 | -47 |
| Purchase Of Investment | -308,006 | -111,009 | -27,704 | -106,725 | -51,318 |
| Sale Of Investment | 111,300 | 48,800 | 23,500 | 134,930 | 102,430 |
| Other Investing Activity | 0 | 0 | 0 | -12,771 | -12,322 |
| Investing Cash Flow | $-196,659 | $-62,135 | $-4,162 | $15,368 | $38,743 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 279,760 | 87,484 | 83,244 | 5,716 | 4,715 |
| Common Stock Repurchased | -105 | -105 | -105 | -95 | -95 |
| Financing Cash Flow | $279,655 | $87,379 | $83,140 | $5,622 | $4,620 |
| Beginning Cash Position | 18,559 | 18,559 | 18,559 | 31,228 | 31,228 |
| End Cash Position | 67,268 | 25,045 | 89,832 | 18,559 | 47,179 |
| Net Cash Flow | $48,709 | $6,486 | $71,273 | $-12,669 | $15,950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,287 | -18,759 | -7,705 | -33,659 | -27,412 |
| Capital Expenditure | -43 | -15 | -5 | -83 | -47 |
| Free Cash Flow | -34,330 | -18,774 | -7,710 | -33,741 | -27,459 |